| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |